Despite modern medical therapies, multiorgan idiopathic inflammatory myopathies (IIM) are associated with reduced quality of life and life expectancy. A systematic review of all published ...

Please provide your email address to receive an email when new articles are posted on . Although lipid-lowering medications are generally well tolerated, rare complications can include ...

Researchers at Johns Hopkins University School of Medicine have identified a subgroup of patients with necrotizing myopathy who have a novel autoantibody specificity that makes them potential ...

Jackson, MS - New research suggests that mycophenolate mofetil (MMF) can be used in the management of autoimmune inflammatory myopathy. The finding, published in the March 2005 issue of Rheumatology, ...

Patient enrollment for idiopathic inflammatory myopathy and stiff person syndrome cohort expected to be initiated in the first quarter of 2025 Company plans to report initial clinical data from Phase ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today provided corporate ...

Immune-mediated necrotizing myopathy typically presents with progressive symmetrical proximal muscle weakness and myalgias, although some cases can present with respiratory and esophageal muscle ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced the ...

Idiopathic inflammatory myopathies (IIM) represent a heterogeneous group of autoimmune disorders primarily characterised by progressive muscle weakness and inflammation, but with potential involvement ...

Malignancies may initially present with muscle weakness and elevated muscle enzymes. Age and gender-specific cancer screening should be completed or updated in those with a myopathic process. 9,10 ...

Please provide your email address to receive an email when new articles are posted on . 47.5% of patients treated with glucocorticoids reported myopathy. Cumulative dosage, age, sex and weight were ...

Swallowing food was strangely difficult, and he was getting weaker by the day. By Lisa Sanders, M.D. “You have to take your husband to the hospital right now,” the doctor urged over the phone. “His ...